Clinical Study At SIU School Of Medicine May Help Your Loved One Suffering from Alzheimer's DiseasePosted:
Springfield- Your loved one suffering from Alzheimer's, may be eligible for a local, clinical trial. Researchers at Southern Illinois University School of Medicine are conducting a clinical trial to test the effectiveness of a treatment for the agitation that often accompanies Alzheimer's disease. Patients may be eligible to participate in the trial if they have moderate to severe agitation due to AD, are between the ages of 50 and 90 and have a caregiver able to attend each study visit.
The TRIAD™ Research Study will include free, study-related medical exams and assessments and potential compensation for time and travel.
SIU says though an estimated five million people in the U.S. currently suffer from Alzheimer's, the U.S. Food and Drug Administration has not approved any new drugs since 2003.
"The impact of Alzheimer's disease both for sufferers and their loved ones is staggering, and many people living with Alzheimer's disease may feel left behind when it comes to options that could improve the quality of life of those dealing with complications like agitation," said Dr. Tom Ala, associate professor of clinical neurology and interim director of SIU School of Medicine's Center for Alzheimer's Disease and Related Disorders..
SIU researchers take part in ongoing, national clinical testing of drugs to treat AD in efforts to improve individuals' ability to function or improve their quality of life.
To learn more about participating in the clinical trial, contact Barbara Lokaitis at email@example.com or 217-545-9737.